Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.
Saved in:
| Title: | Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer. |
|---|---|
| Authors: | Eisses B; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van Geel JJL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherland., Bensch F; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Elias SG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Kuip EJM; Department of Medical Oncology, Radboud Medical Center, Nijmegen, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Vegt B; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lub-de Hooge MN; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherland.; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Emmering J; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands., Arens AIJ; Department of Radiology and Nuclear Medicine, Radboud Medical Center, Nijmegen, The Netherlands., Zwezerijnen GJC; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands., Vugts DJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands., Menke-van der Houven van Oordt CW; Department of Medical Oncology and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; c.schroder@nki.nl.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Oct 01; Vol. 65 (10), pp. 1540-1547. Date of Electronic Publication: 2024 Oct 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39237347 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Eisses+B%22">Eisses B</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Geel+JJL%22">van Geel JJL</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Brouwers+AH%22">Brouwers AH</searchLink>; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherland.<br /><searchLink fieldCode="AU" term="%22Bensch+F%22">Bensch F</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Elias+SG%22">Elias SG</searchLink>; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuip+EJM%22">Kuip EJM</searchLink>; Department of Medical Oncology, Radboud Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jager+A%22">Jager A</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Vegt+B%22">van der Vegt B</searchLink>; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lub-de+Hooge+MN%22">Lub-de Hooge MN</searchLink>; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherland.; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Emmering+J%22">Emmering J</searchLink>; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Arens+AIJ%22">Arens AIJ</searchLink>; Department of Radiology and Nuclear Medicine, Radboud Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Zwezerijnen+GJC%22">Zwezerijnen GJC</searchLink>; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vugts+DJ%22">Vugts DJ</searchLink>; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Menke-van+der+Houven+van+Oordt+CW%22">Menke-van der Houven van Oordt CW</searchLink>; Department of Medical Oncology and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and.<br /><searchLink fieldCode="AU" term="%22de+Vries+EGE%22">de Vries EGE</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schröder+CP%22">Schröder CP</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; c.schroder@nki.nl.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2024 Oct 01; Vol. 65 (10), pp. 1540-1547. <i>Date of Electronic Publication: </i>2024 Oct 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39237347 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2967/jnumed.124.267636 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1540 Titles: – TitleFull: Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Eisses B – PersonEntity: Name: NameFull: van Geel JJL – PersonEntity: Name: NameFull: Brouwers AH – PersonEntity: Name: NameFull: Bensch F – PersonEntity: Name: NameFull: Elias SG – PersonEntity: Name: NameFull: Kuip EJM – PersonEntity: Name: NameFull: Jager A – PersonEntity: Name: NameFull: van der Vegt B – PersonEntity: Name: NameFull: Lub-de Hooge MN – PersonEntity: Name: NameFull: Emmering J – PersonEntity: Name: NameFull: Arens AIJ – PersonEntity: Name: NameFull: Zwezerijnen GJC – PersonEntity: Name: NameFull: Vugts DJ – PersonEntity: Name: NameFull: Menke-van der Houven van Oordt CW – PersonEntity: Name: NameFull: de Vries EGE – PersonEntity: Name: NameFull: Schröder CP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2024 Oct 01 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1535-5667 Numbering: – Type: volume Value: 65 – Type: issue Value: 10 Titles: – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Type: main |
| ResultId | 1 |